Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  eflornithine
Find trials that include:  Any drugs shown
Results 1-6 of 6 for your search:
Start Over
Eflornithine and/or Sulindac in Preventing Recurrence of High-Risk Adenomas and Second Primary Disease in Patients with Stage 0-III Colon or Rectal Cancer
Status: Active
Phase: Phase III
Type: Prevention
Age: 18 and over
Trial IDs: S0820, NCI-2012-02067, SWOG-S0820, NCT01349881
Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients
Status: Active
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: OT-15-001, NCI-2016-01159, NCT02796261
Study of DFMO in Combination With Bortezomib for Relapsed or Refractory Neuroblastoma
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 21 and under
Trial IDs: NMTRC010, NCI-2015-01871, NCT02139397
Neuroblastoma Maintenance Therapy Trial
Status: Active
Phase: Phase II
Type: Prevention, Treatment
Age: 1 to 30
Trial IDs: NMTRC014, NCI-2016-01673, NCT02679144
N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/Topotecan
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 2 to 29
Trial IDs: N2012-01, NCI-2015-00641, P01CA081403, NCT02030964
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Status: Active
Phase: Phase I
Type: Treatment
Age: 1 to 21
Trial IDs: NMTRC012, NCI-2015-01822, NCT02559778
Start Over